![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Opthea: Developing novel therapies for the treatment of eye diseases (PharmaVentures) View |
![]() |
Opthea: OPT-302 (VEGF-C/D trap) for Combination Treatment in nAMD and DME (OIS: Ophthalmology Innovation Source) View |
![]() |
Sozinibercept Offers Hope for Better Vision to Wet AMD Patients (The Ophthalmologist) View |
![]() |
Opthea Eye Phase IIB Trial in 2017 (OIS@AAO 2016) (OIS: Ophthalmology Innovation Source) View |
![]() |
Opthea - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019 (OIS: Ophthalmology Innovation Source) View |
![]() |
Opthea: Targeting a More Complete Blockade of VEGF (OIS@ASRS 2016) (OIS: Ophthalmology Innovation Source) View |
![]() |
Opthea Ltd - Megan Baldwin (ASX) View |
![]() |
OPTHEA - Public Company Spotlight at Ophthalmology Innovation Summit @ AAO 2019 (OIS: Ophthalmology Innovation Source) View |
![]() |
Clearside BioMedical: Drug Delivery to Suprachoroidal Space (OIS: Ophthalmology Innovation Source) View |
![]() |
AdAlta: Developing breakthrough treatments for fibrotic diseases (PharmaVentures) View |